[HTML][HTML] Mechanisms mediating the regulation of peroxisomal fatty acid beta-oxidation by PPARα

M Tahri-Joutey, P Andreoletti, S Surapureddi… - International journal of …, 2021 - mdpi.com
In mammalian cells, two cellular organelles, mitochondria and peroxisomes, share the ability
to degrade fatty acid chains. Although each organelle harbors its own fatty acid β-oxidation …

Therapeutic targets, novel drugs, and delivery systems for diabetes associated NAFLD and liver fibrosis

V Kumar, X **n, J Ma, C Tan, N Osna… - Advanced drug delivery …, 2021 - Elsevier
Type 2 diabetes mellitus (T2DM) associated non-alcoholic fatty liver disease (NAFLD) is the
fourth-leading cause of death. Hyperglycemia induces various complications, including …

Protein–ligand binding with the coarse-grained Martini model

PCT Souza, S Thallmair, P Conflitti… - Nature …, 2020 - nature.com
The detailed understanding of the binding of small molecules to proteins is the key for the
development of novel drugs or to increase the acceptance of substrates by enzymes …

Novel mechanisms for DHEA action

RA Prough, BJ Clark, CM Klinge - Journal of molecular …, 2016 - jme.bioscientifica.com
Dehydroepiandrosterone (3β-hydroxy-5-androsten-17-one, DHEA), secreted by the adrenal
cortex, gastrointestinal tract, gonads, and brain, and its sulfated metabolite DHEA-S are the …

Chlorinated polyfluorinated ether sulfonates exhibit higher activity toward peroxisome proliferator-activated receptors signaling pathways than …

CH Li, XM Ren, T Ruan, LY Cao, Y **n… - … science & technology, 2018 - ACS Publications
Chlorinated polyfluorinated ether sulfonates (Cl-PFAESs) are the alternative products of
perfluorooctanesulfonate (PFOS) in the metal plating industry in China. The similarity in …

Design, synthesis, and evaluation of a novel series of indole sulfonamide peroxisome proliferator activated receptor (PPAR) α/γ/δ triple activators: discovery of …

B Boubia, O Poupardin, M Barth, J Binet… - Journal of medicinal …, 2018 - ACS Publications
Here, we describe the identification and synthesis of novel indole sulfonamide derivatives
that activate the three peroxisome proliferator activated receptor (PPAR) isoforms. Starting …

Targeting the alternative vitamin E metabolite binding site enables noncanonical PPARγ modulation

S Arifi, JA Marschner, J Pollinger, L Isigkeit… - Journal of the …, 2023 - ACS Publications
The lipid-sensing transcription factor PPARγ is the target of antidiabetic thiazolidinediones
(TZD). At two sites within its ligand binding domain, it also binds oxidized vitamin E …

Missing pieces to the endocannabinoid puzzle

M Maccarrone - Trends in molecular medicine, 2020 - cell.com
The most bioactive ingredient of cannabis (Cannabis sativa or indica) extracts, Δ 9-
tetrahydrocannabinol (THC), was identified in the 1960s as one of more than 110 …

Comparing the disrupting effects of short-, medium-and long-chain chlorinated Paraffins on cell viability and metabolism

X Ren, N Geng, H Zhang, F Wang, Y Gong… - Science of the Total …, 2019 - Elsevier
With the phasing out of short-chain chlorinated paraffins (SCCPs), the production and
emissions of medium-and long-chain chlorinated paraffins (MCCPs and LCCPs) are …

Structures of PPARγ complexed with lobeglitazone and pioglitazone reveal key determinants for the recognition of antidiabetic drugs

MA Lee, L Tan, H Yang, YG Im, YJ Im - Scientific reports, 2017 - nature.com
Peroxisome proliferator-activator receptor (PPAR) γ is a nuclear hormone receptor that
regulates glucose homeostasis, lipid metabolism, and adipocyte function. PPARγ is a target …